182 related articles for article (PubMed ID: 22593181)
1. A local paracrine and endocrine network involving TGFβ, Cox-2, ROS, and estrogen receptor β influences reactive stromal cell regulation of prostate cancer cell motility.
Grubisha MJ; Cifuentes ME; Hammes SR; Defranco DB
Mol Endocrinol; 2012 Jun; 26(6):940-54. PubMed ID: 22593181
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Nox4-dependent ROS signaling attenuates prostate fibroblast activation and abrogates stromal-mediated protumorigenic interactions.
Sampson N; Brunner E; Weber A; Puhr M; Schäfer G; Szyndralewiez C; Klocker H
Int J Cancer; 2018 Jul; 143(2):383-395. PubMed ID: 29441570
[TBL] [Abstract][Full Text] [Related]
3. Expression of two WFDC1/ps20 isoforms in prostate stromal cells induces paracrine apoptosis through regulation of PTGS2/COX-2.
Hickman OJ; Smith RA; Dasgupta P; Rao SN; Nayak S; Sreenivasan S; Vyakarnam A; Galustian C
Br J Cancer; 2016 May; 114(11):1235-42. PubMed ID: 27115470
[TBL] [Abstract][Full Text] [Related]
4. Estrogens promote invasion of prostate cancer cells in a paracrine manner through up-regulation of matrix metalloproteinase 2 in prostatic stromal cells.
Yu L; Wang CY; Shi J; Miao L; Du X; Mayer D; Zhang J
Endocrinology; 2011 Mar; 152(3):773-81. PubMed ID: 21248144
[TBL] [Abstract][Full Text] [Related]
5. Metabolic reprogramming of cancer-associated fibroblasts by TGF-β drives tumor growth: connecting TGF-β signaling with "Warburg-like" cancer metabolism and L-lactate production.
Guido C; Whitaker-Menezes D; Capparelli C; Balliet R; Lin Z; Pestell RG; Howell A; Aquila S; Andò S; Martinez-Outschoorn U; Sotgia F; Lisanti MP
Cell Cycle; 2012 Aug; 11(16):3019-35. PubMed ID: 22874531
[TBL] [Abstract][Full Text] [Related]
6. Local endocrine, paracrine and redox signaling networks impact estrogen and androgen crosstalk in the prostate cancer microenvironment.
Grubisha MJ; DeFranco DB
Steroids; 2013 Jun; 78(6):538-41. PubMed ID: 23380371
[TBL] [Abstract][Full Text] [Related]
7. Estradiol modulates TGF-β1 expression and its signaling pathway in thyroid stromal cells.
Gantus MA; Alves LM; Stipursky J; Souza EC; Teodoro AJ; Alves TR; Carvalho DP; Martinez AM; Gomes FC; Nasciutti LE
Mol Cell Endocrinol; 2011 Apr; 337(1-2):71-9. PubMed ID: 21315800
[TBL] [Abstract][Full Text] [Related]
8. NOX4-dependent ROS production by stromal mammary cells modulates epithelial MCF-7 cell migration.
Tobar N; Guerrero J; Smith PC; Martínez J
Br J Cancer; 2010 Sep; 103(7):1040-7. PubMed ID: 20717118
[TBL] [Abstract][Full Text] [Related]
9. Lack of transforming growth factor-β signaling promotes collective cancer cell invasion through tumor-stromal crosstalk.
Matise LA; Palmer TD; Ashby WJ; Nashabi A; Chytil A; Aakre M; Pickup MW; Gorska AE; Zijlstra A; Moses HL
Breast Cancer Res; 2012 Jul; 14(4):R98. PubMed ID: 22748014
[TBL] [Abstract][Full Text] [Related]
10. Silencing of TGF-β1 in tumor cells impacts MMP-9 in tumor microenvironment.
Moore-Smith LD; Isayeva T; Lee JH; Frost A; Ponnazhagan S
Sci Rep; 2017 Aug; 7(1):8678. PubMed ID: 28819116
[TBL] [Abstract][Full Text] [Related]
11. The EPI bioassay identifies natural compounds with estrogenic activity that are potent inhibitors of androgenic pathways in human prostate stromal and epithelial cells.
Vollmer G; Helle J; Amri H; Liu X; Arnold JT
J Steroid Biochem Mol Biol; 2012 Apr; 129(3-5):153-62. PubMed ID: 22207083
[TBL] [Abstract][Full Text] [Related]
12. Increased TGF-β1-mediated suppression of growth and motility in castrate-resistant prostate cancer cells is consistent with Smad2/3 signaling.
Miles FL; Tung NS; Aguiar AA; Kurtoglu S; Sikes RA
Prostate; 2012 Sep; 72(12):1339-50. PubMed ID: 22228025
[TBL] [Abstract][Full Text] [Related]
13. TGFβ1-Endo180-dependent collagen deposition is dysregulated at the tumour-stromal interface in bone metastasis.
Caley MP; Kogianni G; Adamarek A; Gronau JH; Rodriguez-Teja M; Fonseca AV; Mauri F; Sandison A; Rhim JS; Pchejetski D; Palmieri C; Cobb JP; Waxman J; Sturge J
J Pathol; 2012 Apr; 226(5):775-83. PubMed ID: 22072289
[TBL] [Abstract][Full Text] [Related]
14. Effects of androgen receptor and androgen on gene expression in prostate stromal fibroblasts and paracrine signaling to prostate cancer cells.
Tanner MJ; Welliver RC; Chen M; Shtutman M; Godoy A; Smith G; Mian BM; Buttyan R
PLoS One; 2011 Jan; 6(1):e16027. PubMed ID: 21267466
[TBL] [Abstract][Full Text] [Related]
15. Estrogen induces androgen-repressed SOX4 expression to promote progression of prostate cancer cells.
Yang M; Wang J; Wang L; Shen C; Su B; Qi M; Hu J; Gao W; Tan W; Han B
Prostate; 2015 Sep; 75(13):1363-75. PubMed ID: 26015225
[TBL] [Abstract][Full Text] [Related]
16. Adipose tissue-derived stromal cells inhibit TGF-β1-induced differentiation of human dermal fibroblasts and keloid scar-derived fibroblasts in a paracrine fashion.
Spiekman M; Przybyt E; Plantinga JA; Gibbs S; van der Lei B; Harmsen MC
Plast Reconstr Surg; 2014 Oct; 134(4):699-712. PubMed ID: 25357030
[TBL] [Abstract][Full Text] [Related]
17. Nox4-derived ROS signaling contributes to TGF-β-induced epithelial-mesenchymal transition in pancreatic cancer cells.
Hiraga R; Kato M; Miyagawa S; Kamata T
Anticancer Res; 2013 Oct; 33(10):4431-8. PubMed ID: 24123012
[TBL] [Abstract][Full Text] [Related]
18. Stromal transforming growth factor-beta signaling mediates prostatic response to androgen ablation by paracrine Wnt activity.
Placencio VR; Sharif-Afshar AR; Li X; Huang H; Uwamariya C; Neilson EG; Shen MM; Matusik RJ; Hayward SW; Bhowmick NA
Cancer Res; 2008 Jun; 68(12):4709-18. PubMed ID: 18559517
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal Stem Cells are Recruited and Activated into Carcinoma-Associated Fibroblasts by Prostate Cancer Microenvironment-Derived TGF-β1.
Barcellos-de-Souza P; Comito G; Pons-Segura C; Taddei ML; Gori V; Becherucci V; Bambi F; Margheri F; Laurenzana A; Del Rosso M; Chiarugi P
Stem Cells; 2016 Oct; 34(10):2536-2547. PubMed ID: 27300750
[TBL] [Abstract][Full Text] [Related]
20. Silencing of GSTP1, a prostate cancer prognostic gene, by the estrogen receptor-β and endothelial nitric oxide synthase complex.
Re A; Aiello A; Nanni S; Grasselli A; Benvenuti V; Pantisano V; Strigari L; Colussi C; Ciccone S; Mazzetti AP; Pierconti F; Pinto F; Bassi P; Gallucci M; Sentinelli S; Trimarchi F; Bacchetti S; Pontecorvi A; Lo Bello M; Farsetti A
Mol Endocrinol; 2011 Dec; 25(12):2003-16. PubMed ID: 22052999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]